医疗卫生
Search documents
中国驻马里使馆于维华参赞应邀出席马里首届出口日活动
Shang Wu Bu Wang Zhan· 2025-12-10 18:23
Core Points - The first Export Day event in Mali was held on December 7, 2023, in Bamako, aimed at strengthening Mali's economic ties with international markets [1] - The event featured 51 local Malian companies showcasing a diverse range of products, highlighting the richness of local offerings [1] - Chinese companies, including Ganfeng Lithium, Huawei Technologies, Renfu Pharmaceutical, and Mali Bonajihua, participated to demonstrate advanced products and solutions in lithium mining, clean energy, healthcare, and consumer goods manufacturing [1] - The participation of Chinese enterprises reflects the depth and breadth of practical cooperation between China and Mali [1] - The Export Day provided a platform for direct communication between businesses from both countries, facilitating cooperation and injecting new momentum into the China-Mali economic and trade relationship [1]
首版商保创新药目录发布,恒生创新药ETF(159316)获资金持续加仓
Sou Hu Cai Jing· 2025-12-10 11:14
Core Viewpoint - The pharmaceutical sector is experiencing volatility, with Hong Kong stocks continuing to adjust while A-share pharmaceutical stocks saw a slight rebound in the afternoon. The overall market indices for innovative drugs and biotechnology are mixed, indicating varied investor sentiment in the sector [1]. Group 1: Market Performance - The Hang Seng Hong Kong Stock Connect Innovative Drug Index and the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index both declined by 0.7% [1]. - The CSI Innovative Drug Industry Index increased by 0.2%, while the CSI Biotechnology Theme Index rose by 0.3% [1]. - The CSI 300 Pharmaceutical and Health Index saw a gain of 0.4%, reflecting continued capital inflow into the sector [1]. Group 2: Fund Flows - The Hang Seng Innovative Drug ETF (159316) attracted a total of 140 million yuan in the previous two trading days, with an additional net subscription of nearly 10 million shares today [1]. Group 3: Policy Updates - The National Medical Insurance Drug List for 2025 and the first version of the Commercial Health Insurance Innovative Drug List (2025) will be released on December 7, marking the 8th adjustment since the establishment of the National Medical Insurance Bureau [1]. - A total of 114 new drugs will be added to the list, including 50 first-class innovative drugs, targeting key areas such as cancer, chronic diseases, mental health, rare diseases, and pediatric medications [1].
山西:深化医改强根基 健康答卷绘新篇
Zhong Guo Fa Zhan Wang· 2025-12-10 07:58
Core Viewpoint - The health sector in Shanxi has made significant progress during the "14th Five-Year Plan" period, focusing on high-quality development and enhancing public health services, with a commitment to improving the well-being of its residents [2]. Group 1: Public Health System Enhancement - Shanxi has shifted its health work focus from "disease treatment" to "people's health," with per capita public health service subsidies increasing from 79 yuan in 2021 to 94 yuan [3]. - The coverage of 28 free service items now spans the entire life cycle of residents, with vaccination rates and health management for children under 7 remaining above 90% [3]. - The early death rate from major chronic diseases among the 30-70 age group decreased from 18.5% in 2015 to 15.26% in 2023 [3]. Group 2: Medical Service Improvement - The "Strong Medical Project" aims to address issues of accessibility and quality in healthcare, with patient visits and surgeries at national regional medical centers increasing by 47.5% and 45.6%, respectively [4]. - The establishment of 91 county-level medical centers has improved local healthcare capabilities, with 88% of patients receiving care within their counties [4]. - The initiative has also integrated 328 university-trained rural doctors into the healthcare system, ensuring comprehensive service coverage [4]. Group 3: Reform and Innovation - Shanxi has implemented a unified management approach for medical services, with public hospital service revenue now exceeding 30% of total income [6]. - The average hospital stay has been reduced by half a day, and the province has introduced innovative payment models to enhance efficiency [6]. - A digital imaging cloud platform has been established, benefiting over 560,000 patients and saving more than 76 million yuan in costs [6]. Group 4: Focus on Vulnerable Populations - The province has expanded childcare services, with 117 new public childcare institutions established in 2023, achieving full coverage in all counties [7]. - Health services for the elderly have been enhanced, with 80% of secondary hospitals now offering geriatric care [7]. - The promotion of traditional Chinese medicine has been emphasized, with numerous initiatives aimed at integrating these services into the healthcare system [7].
《广州市产业用地指南》公开征询意见 构建四级产业空间保障体系
Guang Zhou Ri Bao· 2025-12-10 02:14
Core Viewpoint - Guangzhou's Planning and Natural Resources Bureau, in collaboration with the Development and Reform Commission, has revised the "Guangzhou Industrial Land Guide" to optimize industrial land use and investment direction, aligning with the "12218" modern industrial system [1] Group 1: Industrial Land Guide - The guide emphasizes principles such as efficient land use, prioritizing advanced industries, and integrating flexible regulations with a focus on operational feasibility [1] - It includes a comprehensive directory of industrial guidance, layout instructions, and various land use guidelines, serving as a technical reference for social investment and industrial upgrades [1] Group 2: Encouraged and Restricted Land Use - The industrial guidance directory is designed to meet Guangzhou's industrial development needs and includes lists of encouraged and restricted land use projects [1] - Specific guidelines are provided for encouraged land use projects based on the industrial chain, site requirements, minimum land area for production lines, factory recommendations, and suggested layout areas [1] Group 3: Land Use Guidelines for Various Sectors - The industrial land guide covers 31 major categories and 179 subcategories for independent manufacturing land use [2] - The service sector land guide addresses 10 categories including technology services, professional services, modern commerce, logistics, and exhibitions [2] - Guidelines for profit-oriented social enterprises include 5 categories such as postal services, sports venues, education, healthcare, and social welfare [2] - Infrastructure land use guidelines encompass 14 categories including transportation, railways, ports, and airports [2]
杭报记者走进甘孜石渠,见证临平援建5年纪实
Hang Zhou Ri Bao· 2025-12-10 01:48
Core Viewpoint - The article highlights the successful collaboration between Linping District and Shiqu County in Sichuan Province, focusing on agricultural development, healthcare improvements, and educational support over the past five years, aiming to enhance the living standards and opportunities for the local population [7][8][11]. Agricultural Development - Linping District has invested 40 million yuan to establish 60 greenhouse structures in Shiqu County, enabling the cultivation of 64 types of fruits and vegetables, with a total output value exceeding 70 million yuan [8]. - The introduction of two new strawberry varieties has led to an impressive yield of 600 kilograms per mu, with the harvesting period extending until May of the following year [8]. - The ecological park has created over 853 job opportunities, benefiting local residents with an annual income of over 40,000 yuan per person [9]. Healthcare Improvements - Linping District has sent 30 medical professionals to Shiqu County, conducting over 50 training sessions and performing 40% of the total surgeries in the county [11]. - Medical professionals from Linping have provided critical healthcare services, including heart examinations for children and advanced surgical procedures, significantly improving local healthcare access [10][11]. Educational Support - Linping District has allocated 107.1 million yuan for the construction and support of educational facilities in Shiqu County, enhancing the learning environment for students [12]. - The district has facilitated the donation of educational materials and equipment, significantly improving the infrastructure of local schools [12]. - Innovative teaching methods introduced by Linping teachers have engaged students and fostered a deeper understanding of various subjects [13][14].
小”医院“纠偏”,向“低效闲置”型资源“动刀
Xin Hua Ri Bao· 2025-12-09 20:53
当下,基层一些医疗、养老等设施存在闲置搁置现象,成为基层群众关注的一个焦点。今年以来,淮安 市洪泽区以排查整治低效闲置资源为主线,组织开展低效闲置资源"纠偏"行动,会同区卫健主管部门着 力推进医疗资源整合重组优化,促进基层医疗机构赋能增效,提升服务群众的能力和水平。 非建制镇卫生院设施闲置、人员冗余——"3+3"划转整合 2014年县(区)行政区划调整后,非建制镇卫生院渐进"赋闲"运行,医疗设施空转、医护人员空耗现象逐 步显现。当前,整治低效闲置资源是整治形式主义为基层减负的一项重要内容。该区卫健主管部门乘势 将仁和等3家非建制镇卫生院,分步整体划转至所属3家建制镇卫生院,推动关联卫生院资源整合重组。 原仁和卫生院相关负责人阮加飞反映,因乡镇撤并引发的蝴蝶效应,该院近些年门可罗雀、门诊量逐年 下降,现在整体划转至岔河镇中心卫生院,设施、人员、业务等将重新调配优化,有很大希望摆脱眼前 的窘境。 该院负责人吴秀智简明介绍:"我们利用'一墙之隔'的地理位置优势,打破'院'墙贯通'院'落,推动建立 镇卫生院、养老院、敬老院'一个法人、一套班子、三块牌子'机制,实行资源要素统筹、医疗服务统 领、经费资金统管,为老年人、 ...
“港澳药械通”第四批指定医疗机构公布
Nan Fang Ri Bao Wang Luo Ban· 2025-12-09 07:25
Core Viewpoint - The Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration have issued a notice regarding the fourth batch of designated medical institutions under the "Hong Kong-Macao Medical Device and Drug Access" initiative, adding 27 new hospitals while removing one [1] Group 1: Designated Medical Institutions - The new designated hospitals include 27 medical institutions such as the Southern Medical University Zhujiang Hospital, while the Foshan Ximalin Shunchao Eye Hospital has been removed from the list [1] - The application process for the fourth batch of designated medical institutions began in August, with a review of the qualifications of the previous three batches [1] - A total of 44 hospitals passed the qualification review, and the current total of designated medical institutions has reached 71 [1] Group 2: Regulatory and Operational Requirements - The notice mandates that relevant municipal administrative departments enhance supervision and management of designated medical institutions [1] - Designated medical institutions are required to deepen cooperation with Hong Kong and Macao in medical services, clinical research, and the importation of medical devices and drugs [1] - The initiative aims to ensure that imported Hong Kong and Macao medical devices and drugs are used solely for specific medical purposes within the institutions, ensuring safety in medication and equipment [1] Group 3: Historical Context and Impact - The "Hong Kong-Macao Medical Device and Drug Access" initiative was officially implemented in Guangdong Province in 2021, with three previous batches of designated institutions announced in August 2021, February 2023, and September 2024 [1] - A total of 140 varieties of drugs and medical devices (63 drugs and 77 devices) have been approved for import and use, benefiting approximately 17,000 patients [1]
菏泽市牡丹人民医院与菏泽家政职业学院、菏泽卫生学校签订协议
Qi Lu Wan Bao· 2025-12-09 06:54
在全体参会人员的共同见证下,双方代表共同签署合作协议,并完成"校企合作基地"授牌,标志着菏泽 市牡丹人民医院与院校的合作正式进入实质性推进阶段。 此次合作是菏泽市牡丹人民医院深化医教协同、履行社会责任的重要实践。未来,医院将严格履行协议 约定,以优质的医疗服务、专业的教学支持,与院校携手共进,既为学生健康保驾护航,也为医学人才 成长搭建阶梯,更为区域卫生健康事业高质量发展贡献一份力量。 为充分发挥医疗机构临床资源优势,保障学生生命健康安全,持续推动区域医教协同高质量发展,12月 4日,菏泽市牡丹人民医院与菏泽家政职业学院、山东省菏泽卫生学校合作签约仪式顺利举行。菏泽市 牡丹人民医院党委书记、院长高庆祥,党委副书记、副院长李国强,副院长王本昀、蔡文,医务科科长 魏贵玲出席仪式,与菏泽家政职业学院党委委员、山东省菏泽卫生学校党委书记王伟献、山东省菏泽卫 生学校校长魏东等院校代表共同擘画合作发展新蓝图。 仪式现场,高庆祥首先代表医院简要介绍发展概况。他表示,菏泽市牡丹人民医院作为区域医疗服务的 重要力量,综合实力突出,不仅拥有完善的临床诊疗体系,更沉淀了丰富的实践教学资源。此次与院校 合作,既要充分发挥医疗优势全力 ...
“港澳药械通”指定医疗机构再扩容
Ren Min Ri Bao· 2025-12-08 20:32
Core Points - The Guangdong Provincial Health Commission and the Guangdong Provincial Drug Administration have released the fourth batch of designated medical institutions under the "Hong Kong-Macao Medical Device and Drug Access" policy, bringing the total to 71 institutions [1] - A total of 140 types of Hong Kong and Macao drugs and medical devices have been approved for use, benefiting approximately 17,000 patients [1] - The policy allows designated medical institutions in the Greater Bay Area to use urgently needed drugs and advanced medical devices that have been approved in Hong Kong and Macao [1] Group 1 - The fourth batch of designated medical institutions includes 27 new hospitals, with 44 hospitals passing the qualification review, and one hospital removed due to closure [1] - Notable new hospitals include Southern Medical University Zhujiang Hospital, Guangzhou Medical University Affiliated Brain Hospital, and Guangdong Second People's Hospital [1] - The "Hong Kong-Macao Medical Device and Drug Access" initiative was officially implemented in 2021, with three previous batches of designated institutions announced in August 2021, February 2023, and September 2024 [2] Group 2 - Local administrative departments are required to strengthen supervision and management of designated medical institutions [2] - Designated institutions are encouraged to deepen cooperation with Hong Kong and Macao in medical services and clinical research [2] - The initiative aims to ensure that imported Hong Kong and Macao medical devices and drugs are used solely for specific medical purposes within the institutions, ensuring safety in their use [2]
钟南山:医学AI要靠更多机构的协作,产学研是关键
Zhong Guo Xin Wen Wang· 2025-12-08 05:53
Core Viewpoint - Medical AI is essential and requires collaboration among multiple institutions rather than individual efforts, emphasizing the importance of industry-academia-research integration for effective implementation [1][2]. Group 1: Medical AI Development - The first Greater Bay Area Medical Artificial Intelligence Conference highlighted the potential of medical AI due to vast industry data and urgent public health needs [2]. - AI cannot replace doctors, as understanding patients' emotional and psychological needs is crucial, which AI cannot analyze [2]. - The uneven distribution of medical resources in China necessitates innovative solutions through new information technologies [2][3]. Group 2: Initiatives for Medical AI - Three key initiatives were proposed: 1. Create a leading national high-quality dataset to empower diagnosis, public health, and new drug development [3]. 2. Accelerate the construction of medical data infrastructure to link comprehensive data resources [3]. 3. Establish an "AI + Healthcare" innovation circle in the Guangdong-Hong Kong-Macao Greater Bay Area to optimize data management and promote data compliance [3]. Group 3: Collaboration and Innovation - There is a call for high-level medical institutions, research institutes, and technology companies to engage in the innovation practices of medical AI in the Greater Bay Area [5].